Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)
Nigeria
· Delayed Price · Currency is NGN 10.40
-0.30 (-2.80%)
At close: Mar 9, 2026
NGX:NEIMETH Cash Flow Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | 2021 - 2017 |
| Net Income | 982.11 | -885.33 | -1,798 | -325.04 | -109.66 | Upgrade
|
| Depreciation & Amortization | 164.92 | 129.99 | 126.09 | 115.96 | 119.57 | Upgrade
|
| Other Amortization | 9.5 | 9.5 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.21 | -3.6 | -0.97 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | -923.66 | -1,068 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 147.69 | - | - | 45.2 | 19.2 | Upgrade
|
| Other Operating Activities | 938.3 | 891.73 | 473.65 | 260.84 | 53.07 | Upgrade
|
| Change in Accounts Receivable | -77.07 | -772.25 | 547.8 | -137.71 | -6.92 | Upgrade
|
| Change in Inventory | -2,025 | 196.94 | -346.13 | -203.78 | -267.21 | Upgrade
|
| Change in Accounts Payable | -2,811 | 1,781 | 1,304 | 378.1 | 213.8 | Upgrade
|
| Change in Other Net Operating Assets | -731.13 | -28.38 | -12.03 | -1.02 | -83.61 | Upgrade
|
| Operating Cash Flow | -3,403 | 396.21 | -773.41 | 132.55 | -61.76 | Upgrade
|
| Capital Expenditures | -224.59 | -702.92 | -936.14 | -1,270 | -1,143 | Upgrade
|
| Sale of Property, Plant & Equipment | 6.96 | 3.6 | 2.25 | - | - | Upgrade
|
| Investing Cash Flow | -217.63 | -699.32 | -933.89 | -1,270 | -1,143 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 913.16 | Upgrade
|
| Long-Term Debt Issued | - | - | 40.64 | - | - | Upgrade
|
| Total Debt Issued | - | - | 40.64 | 2,243 | 913.16 | Upgrade
|
| Long-Term Debt Repaid | -2,183 | -61.85 | -214.58 | - | -537.12 | Upgrade
|
| Total Debt Repaid | -2,183 | -61.85 | -214.58 | -1,888 | -537.12 | Upgrade
|
| Net Debt Issued (Repaid) | -2,183 | -61.85 | -173.95 | 354.58 | 376.04 | Upgrade
|
| Issuance of Common Stock | - | - | 3,710 | - | - | Upgrade
|
| Common Dividends Paid | - | - | - | -106.35 | -132.94 | Upgrade
|
| Other Financing Activities | 5,469 | -866.79 | -816.02 | -358.37 | -239.52 | Upgrade
|
| Financing Cash Flow | 3,286 | -928.64 | 2,721 | -110.15 | 3.58 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 923.58 | 791.25 | -3.43 | 0 | Upgrade
|
| Net Cash Flow | -334.44 | -308.16 | 1,804 | -1,251 | -1,201 | Upgrade
|
| Free Cash Flow | -3,627 | -306.71 | -1,710 | -1,137 | -1,205 | Upgrade
|
| Free Cash Flow Margin | -49.23% | -6.84% | -77.37% | -38.95% | -44.57% | Upgrade
|
| Free Cash Flow Per Share | -0.85 | -0.07 | -0.40 | -0.60 | -0.63 | Upgrade
|
| Cash Interest Paid | 1,217 | 873.32 | 667.95 | 300 | 181.77 | Upgrade
|
| Cash Income Tax Paid | 38 | 12.49 | 125.84 | 53.76 | 31.81 | Upgrade
|
| Levered Free Cash Flow | -4,806 | 1,142 | 722.07 | - | -1,309 | Upgrade
|
| Unlevered Free Cash Flow | -4,042 | 1,687 | 1,140 | - | -1,195 | Upgrade
|
| Change in Working Capital | -5,644 | 1,178 | 1,493 | 35.59 | -143.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.